| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 13.53 mm | 13.53 mm | 13.53 mm | 13.53 mm | 13.53 mm | 13.53 mm |
| Cash burn (monthly) | 4.34 mm | 221.58 k | 7.92 mm | 5.60 mm | 4.89 mm | 4.47 mm |
| Cash used (since last report) | 21.98 mm | 1.12 mm | 40.10 mm | 28.35 mm | 24.76 mm | 22.64 mm |
| Cash remaining | -8.45 mm | 12.41 mm | -26.58 mm | -14.82 mm | -11.23 mm | -9.11 mm |
| Runway (months of cash) | -1.9 | 56.0 | -3.4 | -2.6 | -2.3 | -2.0 |
| 13F holders | Current |
|---|---|
| Total holders | 104 |
| Opened positions | 26 |
| Closed positions | 17 |
| Increased positions | 32 |
| Reduced positions | 20 |
| 13F shares | Current |
|---|---|
| Total value | 48.47 bn |
| Total shares | 41.61 mm |
| Total puts | 42.60 k |
| Total calls | 992.60 k |
| Total put/call ratio | 0.0 |
| Largest owners | Shares | Value |
|---|---|---|
| PFE Pfizer | 7.03 mm | $10.97 bn |
| Lara Sullivan | 4.17 mm | $9.22 mm |
| Laurion Capital Management | 3.63 mm | $5.66 bn |
| BlackRock | 3.34 mm | $5.22 bn |
| Integrated Core Strategies | 3.16 mm | $5.09 mm |
| Millennium Management | 2.98 mm | $4.65 bn |
| World Investments B.V. Bayer | 2.74 mm | $10.34 mm |
| Vanguard | 2.44 mm | $3.81 bn |
| Geode Capital Management | 1.08 mm | $1.69 bn |
| Palo Alto Investors | 1.04 mm | $1.62 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 23 Dec 24 | Yanchik Connealy Pamela | Stock Option Common Stock | Grant | Acquire A | No | No | 1.67 | 310,000 | 517.70 k | 310,000 |
| 23 Dec 24 | Jitendra Wadhane | Stock Option Common Stock | Grant | Acquire A | No | No | 1.67 | 150,000 | 250.50 k | 150,000 |
| 23 Dec 24 | Lara Sullivan | Stock Option Common Stock | Grant | Acquire A | No | No | 1.67 | 1,135,000 | 1.90 mm | 1,135,000 |
| 26 Nov 24 | Yanchik Connealy Pamela | Common Stock | Buy | Acquire P | Yes | No | 1.96 | 83,400 | 163.46 k | 1,199,143 |
| 26 Nov 24 | Yanchik Connealy Pamela | Common Stock | Buy | Acquire P | Yes | No | 2 | 5,450 | 10.90 k | 1,115,743 |
| 10 Jun 24 | Metzger Michael A | Stock Option Common Stock | Grant | Acquire A | No | No | 3.97 | 70,683 | 280.61 k | 70,683 |
